טוען...
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
BACKGROUND: Most women with advanced epithelial ovarian cancer will ultimately develop recurrent disease after completion of initial treatment with primary surgery and adjuvant chemotherapy. Secondary cytoreductive surgery may have survival benefits in selected patients. However, a number of chemoth...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2010
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170993/ https://ncbi.nlm.nih.gov/pubmed/20556785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007822.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|